hydration effects glp-1 receptor agonists weight loss Nutritional priorities to support therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society GLP-1 receptor agonists | How

Beyond that, some other potential risks included sleep issues, low blood pressure (sometimes leading to fainting), kidney stones, arthritis, and acute pancreatitis

And another GLP-1 pill for weight loss is also on its way: Eli Lilly, maker of Zepbound and Mounjaro and a Novo Nordisk competitor, is developing a tablet called orforglipron, which is expected to receive FDA approval this spring.

The same injection site principles that apply to tirzepatide work for semaglutide: abdomen, thigh, or upper arm with consistent rotation to minimize injection site reactions

Gamification and rewards : To boost engagement, gamified features like challenges and rewards for meeting health objectives could be included, potentially integrated with the insurance companys incentive programs